Quantitative real-time RT-PCR of CD24 mRNA in the detection of prostate cancer

[1]  A. Chokkalingam,et al.  Prostate cancer epidemiology. , 2006, Frontiers in bioscience : a journal and virtual library.

[2]  Daniel Q. Naiman,et al.  Robust prostate cancer marker genes emerge from direct integration of inter-study microarray data , 2005, Bioinform..

[3]  K. Desai,et al.  Prostate cancer and the genomic revolution: Advances using microarray analyses. , 2005, Mutation research.

[4]  Robert A Gardiner,et al.  Use of multiple biomarkers for a molecular diagnosis of prostate cancer , 2005, International journal of cancer.

[5]  P. Humphrey,et al.  Prognostic and predictive factors in prostate cancer: Historical perspectives and recent international consensus initiatives , 2005, Scandinavian journal of urology and nephrology. Supplementum.

[6]  Y. Shin,et al.  Cytoplasmic CD24 expression in advanced ovarian serous borderline tumors. , 2005, Gynecologic oncology.

[7]  R. Sutherland,et al.  Molecular markers of prostate cancer outcome. , 2005, European journal of cancer.

[8]  Inge Jonassen,et al.  Gene expression profiles in prostate cancer: association with patient subgroups and tumour differentiation. , 2005, International journal of oncology.

[9]  Christian Pilarsky,et al.  Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival , 2005, The Journal of pathology.

[10]  A. Partin,et al.  Surgical margin status after radical retropubic prostatectomy , 2005, BJU international.

[11]  O. Cussenot,et al.  Cancer de la prostate. Épidémiologie. Facteurs de risques. Anatomopathologie , 2004 .

[12]  W. Isaacs,et al.  Improved biomarkers for prostate cancer: a definite need. , 2004, Journal of the National Cancer Institute.

[13]  S. Loening,et al.  CD24 expression is a significant predictor of PSA relapse and poor prognosis in low grade or organ confined prostate cancer , 2004, The Prostate.

[14]  O. Cussenot,et al.  [Prostate cancer. Epidemiology. Risk factors. Pathology]. , 2004, Annales d'urologie.

[15]  D. Figarella-Branger,et al.  CD24, a signal-transducing molecule expressed on human B lymphocytes, is a marker for human regenerating muscle , 2004, Acta Neuropathologica.

[16]  C. Pilarsky,et al.  CD24 expression is a new prognostic marker in breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Henrik Grönberg,et al.  Prostate cancer epidemiology , 2003, The Lancet.

[18]  I. Petersen,et al.  CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients , 2003, British Journal of Cancer.

[19]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[20]  C. Pilarsky,et al.  CD24 is expressed in ovarian cancer and is a new independent prognostic marker of patient survival. , 2002, The American journal of pathology.

[21]  T. Barrette,et al.  Profiling of cancer cells using protein microarrays: discovery of novel radiation-regulated proteins. , 2001, Cancer research.

[22]  S. Dhanasekaran,et al.  Delineation of prognostic biomarkers in prostate cancer , 2001, Nature.

[23]  W. Liu,et al.  Identification and characterization of amino acid starvation-induced CD24 gene in MCF-7 human breast cancer cells. , 2000, International journal of oncology.

[24]  P. Altevogt,et al.  CD24 is a marker for human breast carcinoma. , 1999, Cancer letters.

[25]  L. Distel,et al.  CD24 promotes invasion of glioma cells in vivo. , 1999, Journal of neuropathology and experimental neurology.

[26]  P. Altevogt,et al.  CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.

[27]  H. Hsu,et al.  Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. , 1995, Cancer research.

[28]  Philip Smith,et al.  Expression of a B‐cell marker, CD24, on nasopharyngeal carcinoma cells , 1995, International journal of cancer.

[29]  J. Kemp,et al.  Expression of CD24 (BA-1) predicts monocytic lineage in acute myeloid leukemia. , 1994, American journal of clinical pathology.

[30]  R. Stahel,et al.  CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. , 1992, Cancer research.

[31]  J. Gogusev,et al.  Expression of the human nephron differentiation molecules in renal cell carcinomas. , 1990, The American journal of pathology.

[32]  T. Lebien,et al.  The human B cell-associated antigen CD24 is a single chain sialoglycoprotein. , 1986, Journal of immunology.

[33]  W. A. Soanes,et al.  Precipitating antigens of the normal human prostate. , 1970, Journal of reproduction and fertility.